Rogosin Institute Inc
- Assets
- $117.9m
- Revenue
- $116.5m
- Investments
- $136.3k
- Employees
- 592
- Location
- New York, NY
- Founding
- 04/2000
- Data as of
- 12/2022
- EIN
- 13-3184198
Organization Overview
Rogosin Institute Inc is located in New York, NY. The organization was established in 2000. According to its NTEE Classification (E05) the organization is classified as: Research Institutes & Public Policy Analysis, under the broad grouping of Health Care and related organizations. As of 12/2022, Rogosin Institute Inc employed 592 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Rogosin Institute Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Rogosin Institute Inc generated $116.5m in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 2.4% each year. All expenses for the organization totaled $123.9m during the year ending 12/2022. While expenses have increased by 3.3% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
TO PROVIDE THE HIGHEST QUALITY COMPREHENSIVE CARE FOR PEOPLE WITH KIDNEY DISEASE USING A MULTIFACETED INTEGRATIVE APPROACH THAT EMPHASIZES INNOVATIVE TREATMENT OPTIONS AND EDUCATION.
Describe the Organization's Program Activity:
Part 3 - Line 4a
DIALYSIS FACILITY: PROVIDES IN-CENTER, HOME HEMODIALYSIS AND PERITONEAL DIALYSIS SERVICES FOR PATIENTS WITH KIDNEY FAILURE (END-STAGE KIDNEY DISEASE) THROUGH 10 CENTERS IN NEW YORK CITY, BROOKLYN, QUEENS AND THE BRONX.
OTHER PROGRAM SERVICES REVENUE AND EXPENSES
IMMUNOGENETICS AND TRANSPLATATION CENTER: A HISTOCOMPATIBILITY LABORATORY THAT PERFORMS TISSUE TYPING EVALUATIONS TO FACILITATE ORGAN TRANSPLANTATION.
RESEARCH: BASIC SCIENCE AND CLINICAL RESEARCH PROGRAM STUDYING KIDNEY DISEASE, RENAL REPLACEMENT THERAPY (DIALYSIS, KIDNEY TRANSPLANTATION) AND REGENERATIVE MEDICINE. THE PROGRAM DEVELOPS AND TESTS NEW THERAPEUTIC MODALITIES FOR KIDNEY DISEASE AND ITS CAUSES, INCLUDING DIABETES, LIPID DISORDERS AND CARDIOVASCULAR DISEASE.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Name Not Listed Evp/clinical Service & Strategy | OfficerTrustee | 35 | $474,564 |
Name Not Listed VP Nephrology/dialysis & Cmo | OfficerTrustee | 35 | $471,086 |
Name Not Listed Vice Chair | OfficerTrustee | 1 | $0 |
Name Not Listed Treasurer | OfficerTrustee | 1 | $0 |
Name Not Listed Chariman | OfficerTrustee | 5 | $0 |
Name Not Listed Secretary | OfficerTrustee | 1 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Weill Cornell Medical College Leased Physician Services | 12/30/22 | $1,762,355 |
Taconic Management Company Llc Property Management Services | 12/30/22 | $1,626,066 |
Ascend Clinical Llc Lab Testing | 12/30/22 | $1,347,690 |
Cbm Solutions Llc Financial Services | 12/30/22 | $631,752 |
Hm Hughes Co Inc Construction Services | 12/30/22 | $1,151,237 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $113,944 |
| Related organizations | $0 |
| Government grants | $1,651,200 |
| All other contributions, gifts, grants, and similar amounts not included above | $3,517,629 |
| Noncash contributions included in lines 1a–1f | $46,269 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $5,282,773 |
| Total Program Service Revenue | $107,301,973 |
| Investment income | $1,534,453 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $681,222 |
| Net Income from Fundraising Events | -$2,632 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $116,515,923 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $849,660 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $3,239,254 |
| Compensation of current officers, directors, key employees. | $3,239,254 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $52,087,669 |
| Pension plan accruals and contributions | $1,034,500 |
| Other employee benefits | $9,156,688 |
| Payroll taxes | $2,748,600 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $400,716 |
| Fees for services: Accounting | $297,017 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $113,170 |
| Fees for services: Other | $7,532,363 |
| Advertising and promotion | $90,867 |
| Office expenses | $11,763,275 |
| Information technology | $837,194 |
| Royalties | $0 |
| Occupancy | $10,251,802 |
| Travel | $228,117 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $84,959 |
| Interest | $1,527,389 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $3,819,294 |
| Insurance | $1,132,377 |
| All other expenses | $0 |
| Total functional expenses | $123,934,554 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $3,213,012 |
| Savings and temporary cash investments | $708,142 |
| Pledges and grants receivable | $396,575 |
| Accounts receivable, net | $19,998,572 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $866,204 |
| Prepaid expenses and deferred charges | $989,979 |
| Net Land, buildings, and equipment | $29,005,287 |
| Investments—publicly traded securities | $14,916,807 |
| Investments—other securities | $136,272 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $47,704,833 |
| Total assets | $117,935,683 |
| Accounts payable and accrued expenses | $12,822,291 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $1,350,040 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $96,927,072 |
| Total liabilities | $111,099,403 |
| Net assets without donor restrictions | $2,189,175 |
| Net assets with donor restrictions | $4,647,105 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $117,935,683 |
Grants Awarded
Over the last fiscal year, Rogosin Institute Inc has awarded $849,660 in support to 2 organizations.
| Grant Recipient | Amount |
|---|---|
UT SOUTHWESTERN MEDICAL CENTER PURPOSE: SUPPORT | $607,966 |
THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA AT BIRMINGHAM PURPOSE: SUPPORT | $241,694 |